Shree-Janak Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Shree-Janak Pharmacy
Shree-Janak Pharmacy Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2021 (Three years and eight months 27 days old ). Its registered office is in Gwalior, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bhagwati Gupta, Jyoti Gurjar, Vinod Gupta, and Four other members serve as directors at the Company.
Company Details
-
Location
Gwalior, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MP2021PTC056098
-
Company No.
056098
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Shree-Janak Pharmacy?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagwati Gupta
|
Director | 18-May-2021 | Current |
|
Jyoti Gurjar
|
Director | 01-Aug-2022 | Current |
|
Vinod Gupta
|
Director | 01-Aug-2022 | Current |
|
Hakim Jadon
|
Director | 18-May-2021 | Current |
|
Ajay Garg
|
Director | 27-Jun-2022 | Current |
|
Rameshwar Gurjar
|
Director | 27-Jun-2022 | Current |
Financial Performance of Shree-Janak Pharmacy.
Enhance accessibility to Shree-Janak Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree-Janak Pharmacy?
Unlock access to Shree-Janak Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
G5 Remedies Private LimitedBhagwati Gupta, Jyoti Gurjar and 1 more are mutual person
-
Bioshi Pharmaceutical Private Limited
Hakim Jadon is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree-Janak Pharmacy?
Shree-Janak Pharmacy has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree-Janak Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree-Janak Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.